To stop or not to stop: the quest for long-term viral suppression

J Gastroenterol Hepatol. 2011 Mar;26(3):420-2. doi: 10.1111/j.1440-1746.2011.06604.x.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Alanine Transaminase / blood
  • Antiviral Agents / administration & dosage*
  • Biomarkers / blood
  • DNA, Viral / blood
  • Drug Administration Schedule
  • Drug Monitoring
  • Hepatitis B Surface Antigens / blood
  • Hepatitis B e Antigens / blood
  • Hepatitis B virus / genetics
  • Hepatitis B virus / immunology
  • Hepatitis B, Chronic / diagnosis
  • Hepatitis B, Chronic / drug therapy*
  • Humans
  • Lamivudine / administration & dosage*
  • Predictive Value of Tests
  • Recurrence
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Viral Load

Substances

  • Antiviral Agents
  • Biomarkers
  • DNA, Viral
  • Hepatitis B Surface Antigens
  • Hepatitis B e Antigens
  • Lamivudine
  • Alanine Transaminase